lysander72

Author Archives

I found this to be a very interesting article on the prospects for Africa. http://mises.org/daily/6511/Africa-The-Next-Major-BoomBust-Cycle I thought of Lonrho but see that was bought out months ago, I missed that. In any case, I do own Taipan, an oil explorer in Kenya, so I found the article relevant

For your consideration: I stumbled across Chris Mayer’s tease of “The biggest fire sale in history”. http://dailyreckoning.com/the-biggest-fire-sale-in-history/ Some highlights: “This is our opportunity. There is no better, more-reliable way to make money than to buy something from someone who has to sell. Bankers are the best people in the world to buy from. Believe me, […]

DISCOVER MICKLE OIL RICHES USING THIS COMPANY’S VIRTUAL DOWSING ROD TO PRACTICALLY PRINT MONEY! (Eat your heart out Ben Bernanke!!) Many investors spend countless hours scouring insider trading reports, reading tedious geological reports, and spending thousands of dollars on newsletters in an attempt to find the perfect junior oil explorer. And when they are confident […]

Recent Author Comments

On Friday File: More on Coinbase and Bitcoin, Quarters from Crown Castle and Intuitive Surgical, and more...

Totally agree on I-Bonds. About IPOs. You mention Fortegra's original S-1 had a placeholder amount of $100 million. I am watching Atai, they also use $100 million in their initial filing. How does this work? I assume the underwriters are gauging interest i[...]

Go to Comment »
On Friday File: Cheaper SPACs and a Year to Remember

Thanks. I found this to be an interesting article: The lowdown on SPACs and the paper that's the basis for the article https://clsbluesky.law.columbia.edu/2021/03/11/the-lowdown-on-spacs/ https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3775847[...]

Go to Comment »
On Friday File: Cheaper SPACs and a Year to Remember

accelerateshares.com/investment-solutions/arb-2/?mc_cid=0388f0531b&mc_eid=080ace7045[...]

Go to Comment »
On Friday File: Cheaper SPACs and a Year to Remember

SPAC Arbitrage is an investment strategy that seeks to acquire shares or units of a special purpose acquisition company (“SPAC”) at or below its net asset value (“NAV”) in order to generate a return through either: an exit at a premium to NA[...]

Go to Comment »
On Friday File: Cheaper SPACs and a Year to Remember

Speaking of SPACs, any interest in Accelerate Arbitrage Fund (ARB.TO)? I have been watching it but haven't pulled the trigger yet.[...]

Go to Comment »
On Gone Fishin'

Have a good time. Thanks for all you do here.[...]

Go to Comment »
On What's Matt Badiali's "Magic Metal" Pitch About?

Vendetta Mining VTT.V (VDTAF) is a recommended pick of Eric Coffin and John Kaiser follows it too. Vendetta just closed a placement so they are financed up. Also, a new resource estimate is expected by the end of the month. Disclosure: I bought in at 10 ce[...]

Go to Comment »
On Supplements and Drugs: the Feud Redux

"Does the FDA attempt to suppress information about drug adverse effects? On the contrary: the FDA requires pharmaceutical companies to reveal all potential drug adverse effects in overwhelming detail" Has the author ever heard of Vioxx? The author misses [...]

Go to Comment »
On Friday File: The Dark and Ugly Start of 2016

As far as Input Capital goes, it had been its policy to issue a NR with preliminary revenues with an optimistic tone within a week of the quarter's ending, no such NR this month which worries me enough to close my small position.[...]

Go to Comment »
On November "Idea of the Month" Is a Buy from the Watchlist, Plus an Update on Crius

FWIW according to Canadianinsider two insiders of Input, Emsley and Farquhar, purchased shares on Friday, 30,000 and 15,000 respectively.[...]

Go to Comment »
On Is a "World-Class Mine Well Outside the ISIS Conflict" Setting a Company up to skyrocket 2,448%?

Ah, Erin, I owned it a few years ago but eventually became disenchanted with management. As goes the old adage: mines are made and not discovered. (or something like that). Though back then, before ISIS, the theme was the superior quality of Erin's boron i[...]

Go to Comment »
On November "Idea of the Month" Is a Buy from the Watchlist, Plus an Update on Crius

If I may add a thought, it always puzzled me how streaming companies would claim that somehow they were immune to the problems which dogged the operating company of the mine or farm in this case. While the risks may be lessened by diversification they stil[...]

Go to Comment »
On November "Idea of the Month" Is a Buy from the Watchlist, Plus an Update on Crius

Nice summary of Input, pretty much my thinking although yours is much more detailed and concise. I also bought a small position and will wait to see what happens next. Thanks for your thoughts.[...]

Go to Comment »
On Revealing "Greenland's Gift" as teased by Penny Stock Millionaire

Financing is a major concern in this market. I am comfortable waiting to see if the company can raise money and at what price, there will still be time to jump in after that.[...]

Go to Comment »
On Casey's "7 Top Gold Stocks with Vertical Potential"

Brent was on BNN recently and is always interesting to listen to. Here are his top picks from the program. http://www.bnn.ca/Video/player.aspx?vid=563719 I prefer HardRockanalyst to anything that Casey publishes. Coffin, of HardRock, is involved in Pre[...]

Go to Comment »
On Microblog: Gumshoe BioDimSum II: Corralling the "A" Biotechs Plus a New Long Selection

For any newbie investors in biotechs, this is an extremely risky field. The similarities between investing in bios and junior gold are many and telling. On to AKAO. In their 10-K three significant points are made. There will be changes to the timetable, a[...]

Go to Comment »
On Microblog: The Zed Files

For any newbie investors in biotechs, slate ran an interesting article recently. Gives a little more realistic view on the FDA and the studies it "supervises". http://www.slate.com/articles/health_and_science/science/2015/02/fda_inspections_fraud_fabricati[...]

Go to Comment »
On "One of the best biotech companies that I’ve ever looked at..." Plus some updates for the Friday File

Yes, ZENO is a pump and dump[...]

Go to Comment »
On Microblog: Thoughts from Myron—October is Prospect Generator Month

Tread carefully, Megan, it is a perilous hobby as Myron wrote. I first heard of Avrupa when it was in the 30 cent range. I haven't followed it closely enough to be specific, but I think the prospect generator model, in vogue nowadays, works better in th[...]

Go to Comment »
On Microblog: What’s behind the deep dark plot to keep miracle cures concealed from the public?

Thanks, agree 100% with what you wrote, saved me a lot of time. Doc does describe the long,expensive route to drug approval quite well which is why I won't invest in bio-tech. Give me Canadian juniors, lol.[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info